Archive for July 2nd, 2012

PATH expects to resubmit NDA in July. CORT offering. AMLN buyout + CRTX MNTA INFI INSM MDCO news

Jul 02, 2012 No Comments by

NuPathe Inc. (NASDAQ: PATH) announced that it expects to resubmit its NDA in July 2012, for its  migraine patch (NP101) and anticipates a six-month review by the FDA. Corcept Therapeutics Incorporated (NASDAQ: CORT)  today announced that it intends to issue 11m shares of its common stock in an underwritten public offering, with an option to issue to an additional […]

Daily News Read more